Margarita del Val

Margarita del Val was born in Madrid in 1959 to the chemists Manuel del Val and Consuelo Latorre. del Val attended the Autonomous University of Madrid (UAM) starting in 1976, during the Transition. During this time, increasing protests on university grounds against the Francoist dictatorship culminated in all Spanish universities going on strike starting in 1973, which was ongoing when she arrived at the university. ==Career==

In the 1980s, del Val began working at the , a research institute at the UAM jointly run by the university and the CSIC. She then spent three years at the University of Ulm. del Val returned to Spain in the 1990s, having developed an experimental vaccine design based on isolated T-cell epitopes. Afterwards, del Val stayed abroad at the National Institutes of Health in Bethesda, Maryland and McGill University in Montreal, before spending twenty years at the Carlos III Health Institute. In April 2020, del Val helped set up and launch the Salud Global ("Global Health") program, a CSIC project facilitating COVID-19 research between over 300 Spanish research groups. del Val has provided her thoughts on Spain's experience with the COVID-19 pandemic == Selected publications ==

In 2015 del Val was named a corresponding academician of the Royal Academy of Pharmacy. In 2021 she received the "Medalla de Honor a los Valores Sociales" from Menéndez Pelayo International University for her work in Spain during the COVID-19 pandemic. ==Personal life==

del Val is married to the biologist Enrique J. de la Rosa, who she met at the UAM in 1977. She has a son and daughter. ==References==